Advertisement

Neuroendocrine Control of Pituitary Function in Extrapiramidal Disorders

  • T. Caraceni
  • P. Giovannini
  • E. Parati
  • G. Scigliano
  • E. E. Müller

Abstract

The purpose of this study was to reconsider the functional status of the hypothalamus-pituitary axis in diseases of the extrapyramidal system. The theme of the paper is behavior of the secretion of growth hormone (GH), thyroid-stimulating hormone (TSH), and prolactin (PRL), particularly in Huntington’s disease (HD) and Parkinson’s disease (PD). The choice of these hormones derives from the fact that their secretion is under a dopaminergic control1 and that this latter function is notedly involved in the pathologies under examination.

Keywords

Growth Hormone Growth Hormone Response Parkinsonian Patient Basal Growth Hormone Level Control Growth Hormone Secretion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    E. E. Miiller, G. Nistico and U. Scapagnini, “Neurotransmitters and Anterior Pituitary Function,” Academic Press, New York (1978).Google Scholar
  2. 2.
    G. W. Bruyn, Huntington’s chorea, history, clinical and laboratory synopsis, in: “Handbook of Clinical Neurology,” vol. 6, P. J. Vinken and G. W. Bruyn, eds., North-Holland, Amsterdam (1968).Google Scholar
  3. 3.
    E. D. Bird, Neuroendocrine changes in Huntington’s disease — An overview, Adv Neurol 23:291 (1979).Google Scholar
  4. 4.
    H. J. Keogh, R. H. Johnson, R. N. Nanda and W. R. Sulaiman, Altered growth hormone release in Huntington’s chorea, J. Neurol Neurosurg Psychiat 39:244 (1976).PubMedCrossRefGoogle Scholar
  5. 5.
    N. A. Leopold and S. Podolsky, Exaggerated growth hormone response to arginine infusion in Huntington’s disease, J .Clin Endocrinol Metab 41:160 (1975).PubMedCrossRefGoogle Scholar
  6. 6.
    P. J. M. Lavin, I. Bone and P. Sheridan, Studies of hypothalamic function in Huntington’s chorea, J Neurol Neurosurg Psychiat 44:414 (1981).PubMedCrossRefGoogle Scholar
  7. 7.
    R. Durso, C. A. Tanninga, A. Denaro, S. Ruggeri and T. N. Chase, Plasma growth hormone and prolactin response to dopaminergic GABA mimetic and cholinergic stimulation in Huntington’s disease, Neurology 33:1229 (1983).PubMedCrossRefGoogle Scholar
  8. 8.
    T. A. Caraceni, E. A. Parati, P. M. Giovannini et al., Neuroendocrinological findings in untreated huntingtonian patients, Arch Neurol in press (1983).Google Scholar
  9. 9.
    A. Destee, H. Petit, P. Fossati and P. Warot, Choree de Huntington et hormone somatotrope: explorations dynamiques dans 27 cas, Rev Neurol, 137:21 (1981).PubMedGoogle Scholar
  10. 10.
    E. E. Miiller, E. A. Parati, D. Cocchi, D. Zanardi and T. Caraceni, Dopaminergic drugs on growth hormone and prolactin secretion in Huntington’s disease, Adv Neurol 23:319 (1979).Google Scholar
  11. 11.
    A. Polleri, F. Savoldi, A. Muratorio et al., Circadian rhythmicity of prolactin secretion in Huntington’s chorea, Life Sci 26:1609 (1980).PubMedCrossRefGoogle Scholar
  12. 12.
    R. J. Chalmers, R. H. Johnson, H. J. Keogh and R. N. Nanda, Growth hormone and prolactin response to bromocriptine in patients with Huntington’s chorea, J Neurol Neurosurg Psychiat 41:135 (1978).PubMedCrossRefGoogle Scholar
  13. 13.
    M. R. Hayden, M. Paul, A. I. Vinik and P. Beighton, Impaired prolactin release in Huntington’s chorea, Lancet 2:423 (1977).PubMedCrossRefGoogle Scholar
  14. 14.
    J. W. Langston and C. S. Forno, The hypothalamus in Parkinson’s disease, Ann Neurol 3:129 (1978).PubMedCrossRefGoogle Scholar
  15. 15.
    E. Ohama and F. Ikuta (1976) Parkinson’s disease: distribution of Lewy bodies and monoamine neuron system, Acta Neuropathol (Berlin) 34:311 (1976).CrossRefGoogle Scholar
  16. 16.
    P. O. Lundberg, Blood levels of FSH, LH, TSH and GH in parkinsonian patients before and during L-dopa treatment, Acta Neurol Scand 48:427 (1972).PubMedCrossRefGoogle Scholar
  17. 17.
    A. Martinez-Campos, P. Giovannini, E. Parati et al., Growth hormone and prolactin stimulation by Madopar in Parkinson’s disease, J Neurol Neurosurg Psychiat 44:1116 (1981).PubMedCrossRefGoogle Scholar
  18. 18.
    L. Murri, A. Iudice, A. Muratorio et al., Spontaneous nocturnal plasma prolactin and growth hormone secretion in patients with Parkinson’s disease and Huntington’s chorea, Eur Neurol, 19:198 (1980).PubMedCrossRefGoogle Scholar
  19. 19.
    H. E. Carlson, J. C. Gillin, P. Görden and F. Snyder, Absence of sleep-related growth hormone peaks in aged normal subjects and acromegaly, J Clin Endocrinol Metab 34:1102 (1972).PubMedCrossRefGoogle Scholar
  20. 20.
    F. Cavagnini, M. Peracchi, G. Scotti et al., Effect of L-dopa administration on growth hormone secretion in normal subjects and parkinsonian patients, J Endocrinol 54:425 (1972).PubMedCrossRefGoogle Scholar
  21. 21.
    J. D. Parkes, A. G. Debono and C. D. Marsden, Growth hormone response in Parkinson’s disease, Lancet 1:483 (1976).PubMedCrossRefGoogle Scholar
  22. 22.
    P. J. M. Lavin, M. J. Gadwell, P. K. Das et al., Effect oflevodopa on thyroid function and prolactin release, Arch Neurol 38:759 (1981).PubMedCrossRefGoogle Scholar
  23. 23.
    A. Martinez-Campos, P. Giovannini, A. Novelli et al., Thyrotropin and prolactin responses to thyrotropin-releasing hormone in patients with Parkinson’s disease, Acta Endocrinol 99:344 (1982).PubMedGoogle Scholar
  24. 24.
    A. Polleri, P. Masturzo, G. Muriaido et al., Chronobiology of prolactin secretion: a marker in physiology and pathology, in: “Central and Peripheral Regulation of Prolactin Function,” R. M. MacLeod and U. Scapagnini, eds., Raven Press, New York (1980).Google Scholar
  25. 25.
    P. J. Snyder and R. D. Utiger, Response to thyrotropin-releasing hormone (TRH) in normal men, J Clin Endocrinol Metab 34:380 (1972).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1985

Authors and Affiliations

  • T. Caraceni
    • 1
  • P. Giovannini
    • 1
  • E. Parati
    • 1
  • G. Scigliano
    • 1
  • E. E. Müller
    • 1
  1. 1.Istituto Neurologico C. BestaMilanoItaly

Personalised recommendations